Taku Oikawa
Overview
Explore the profile of Taku Oikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takahara Y, Abe R, Sumito N, Tanaka T, Ishige Y, Shionoya I, et al.
Thorac Cancer
. 2024 Mar;
15(12):987-993.
PMID: 38485287
Background: Pemetrexed (PEM) is the primary chemotherapy for non-small cell lung cancer (NSCLC), showing potential for long-term disease stability in certain cases. However, studies examining disease control with PEM therapy...
2.
Kawasaki Y, Nishiki K, Nojiri M, Kato R, Shinomiya S, Oikawa T, et al.
Respir Investig
. 2023 Dec;
62(1):143-149.
PMID: 38134662
Background: Sarcopenia, characterized by skeletal muscle atrophy and physical inactivity, is a manifestation of chronic obstructive pulmonary disease (COPD) and is associated with a poor prognosis. The serum creatinine (Cr)/cystatin...
3.
Takahara Y, Abe R, Nagae S, Tanaka T, Ishige Y, Shionoya I, et al.
Thorac Cancer
. 2023 Nov;
14(36):3549-3555.
PMID: 37964501
Background: Several options for second-line therapy are available for patients with advanced non-small cell lung cancer (NSCLC); however, the optimal therapy remains unclear. Docetaxel (DTX) monotherapy and DTX plus ramucirumab...
4.
Takahara Y, Abe R, Sumito N, Tanaka T, Ishige Y, Shionoya I, et al.
Thorac Cancer
. 2023 Aug;
14(27):2754-2760.
PMID: 37536667
Background: Immune checkpoint inhibitor (ICI) monotherapy is currently approved for the treatment of advanced non-small cell lung cancer (NSCLC) patients with programmed death ligand-1 (PD-L1) expression ≥50%. However, the efficacy...
5.
Shinomiya S, Tanaka T, Shionoya I, Mura T, Nakase K, Takahara Y, et al.
Ther Adv Infect Dis
. 2023 Jun;
10:20499361231179863.
PMID: 37363443
is a bacteria often detected in soil, and is known as a rare cause of infections in Japan. In addition, detection of this species is often overlooked due to negative...
6.
Takahara Y, Tanaka T, Ishige Y, Shionoya I, Yamamura K, Sakuma T, et al.
Thorac Cancer
. 2023 Mar;
14(14):1286-1293.
PMID: 36994539
Background: Amrubicin (AMR) has become the standard of care for post-relapse small cell lung cancer (SCLC). It has also been reported to achieve long-term disease control in patients with good...
7.
Takahara Y, Tanaka T, Ishige Y, Shionoya I, Yamamura K, Sakuma T, et al.
Cancer Rep (Hoboken)
. 2022 Nov;
6(1):e1754.
PMID: 36366956
Background: Large cell neuroendocrine tumors of the lung (LCNEC) are rare. Chemotherapy with the small cell lung carcinoma (SCLC) regimen is the most appropriate treatment for LCNEC. However, there is...
8.
Takahara Y, Tanaka T, Ishige Y, Shionoya I, Yamamura K, Sakuma T, et al.
Thorac Cancer
. 2022 Oct;
13(24):3451-3458.
PMID: 36281714
Background: The clinical characteristics and risk factors for cancer recurrence have not been well evaluated regarding early recurrence in patients with unresectable locally advanced non-small cell lung cancer (LA-NSCLC) who...
9.
Yamamura K, Nojiri M, Nishiki K, Kato R, Shinomiya S, Takahara Y, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 Jul;
17:1589-1600.
PMID: 35854898
Purpose: Oxidative stress is known to activate tumor suppressor p53, which inhibits cell cycle progression and induces apoptosis. Levels of p53 in lung tissues from patients with chronic obstructive pulmonary...
10.
Takahara Y, Shionoya I, Shioya A, Shinomiya S, Oikawa T, Yamada S, et al.
Respir Med Case Rep
. 2022 Jul;
38:101694.
PMID: 35799861
In cases wherein metastatic disease diagnosis in lung cancer is difficult with imaging, tissue biopsy should be performed. A 77-year-old woman presented with a complaint of cough. Positron emission tomography-computed...